We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Oncology Institute Inc (TOI) USD0.0001

Sell:$0.32 Buy:$0.33 Change: $0.0156 (5.05%)
Market closed |  Prices as at close on 2 January 2025 | Switch to live prices |
Sell:$0.32
Buy:$0.33
Change: $0.0156 (5.05%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 2 January 2025 | Switch to live prices |
Sell:$0.32
Buy:$0.33
Change: $0.0156 (5.05%)
Market closed |  Prices as at close on 2 January 2025 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Contact details

Address:
18000 Studebaker Rd, Suite 800
CERRITOS
90703
United States
Telephone:
+1 (562) 7353226
Website:
https://theoncologyinstitute.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TOI
ISIN:
US68236X1000
Market cap:
$23.35 million
Shares in issue:
75.56 million
Sector:
Health Care Facilities
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Daniel Virnich
    Chief Executive Officer, Director
  • Robert Carter
    Chief Financial Officer, Principal Accounting Officer
  • Jeremy Castle
    Chief Operating Officer
  • Jordan Mcinerney
    Chief Development Officer
  • Yale Podnos
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.